Citations

Citations to this article as recorded by  

• The interplay between lymphatic system and portal hypertension: a comprehensive review
  Pinky Juneja, Rajni Yadav, Dinesh M. Tripathi, Savneet Kaur
  Hepatology International.2025; 19(4): 720.     CrossRef

Citations

Citations to this article as recorded by  

• Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases
  Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung
  Journal of Korean Medical Science.2026;[Epub]     CrossRef
• Chronic comorbidities, concomitant medications, and treatment patterns of chronic hepatitis B patients receiving nucleos(t)ide analogue therapy: a hospital claims database study in Japan
  Daisuke Nakamoto, Emi Ohata, Mayumi Yuda, Nobuyuki Fukui, Nao Makino, Rie Kanamori, Nozomi Aoki, Akio Kanazawa, Hirotake Mori, Yuji Nishizaki, Hirohide Yokokawa, Yuichiro Yano, Toshio Naito
  BMC Infectious Diseases.2026;[Epub]     CrossRef
• A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
  Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
  Journal of Hepatology.2025; 82(2): 235.     CrossRef
• Impact of Maternal Hepatitis B Virus Infection on Congenital Heart Disease Risk in Offspring: A National Cohort Study
  Yewan Park, Jihye Heo, Danbee Kang, Geum‐Youn Gwak
  Journal of Viral Hepatitis.2025;[Epub]     CrossRef
• A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis B
  Yeonjung Ha, Seungseok Lee, Jihye Lim, Kwanjoo Lee, Young Eun Chon, Joo Ho Lee, Kwan Sik Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Dong Keon Yon, Jinseok Lee, Han Chu Lee
  Liver International.2025;[Epub]     CrossRef
• AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
  Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
  Journal of Hepatology.2025; 82(6): 1080.     CrossRef
• Accelerating the momentum to achieve global elimination of hepatitis B infection: a scoping review of hepatitis B guidelines to reduce mother to child transmission
  Ka Wang Cheung, Ying Rong Li, Ms Tiffany Sin-Tung Au, Mimi Tin Yan Seto
  eClinicalMedicine.2025; 80: 103038.     CrossRef
• Effect of invasive tests during pregnancy on perinatal transmission of hepatitis B infection: a scoping review
  Ka Wang Cheung, Tiffany Sin-Tung Au, Ying Rong Li, Zhenyan Han, Zhu Zhang, Mimi Tin Yan Seto
  eClinicalMedicine.2025; 80: 103039.     CrossRef
• Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
  Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(1): 131.     CrossRef
• Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
  Log Young Kim, Jae Young Kim, Jeong‐Ju Yoo, Sang Gyune Kim, Young‐Seok Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
  Jung Hee Kim, Sung-Eun Kim, Do Seon Song, Hee Yeon Kim, Eileen L. Yoon, Ji Won Park, Tae Hyung Kim, Young-Kul Jung, Ki Tae Suk, Hyung Joon Yim, Jung Hyun Kwon, Sung Won Lee, Seong Hee Kang, Moon Young Kim, Soung Won Jeong, Jae-Young Jang, Jeong Ju Yoo, Sa
  Annals of Medicine.2025;[Epub]     CrossRef
• The sV184A Variant in HBsAg Specific to HBV Subgenotype C2 Leads to Enhanced Viral Replication and Apoptotic Cell Death Induced by PERK‐eIF2α‐CHOP‐Mediated ER Stress
  Yu‐Min Choi, Dong Hyun Kim, Eun Ju Cho, Ziyun Kim, Junghwa Jang, Hyunsoo Kim, Su Jong Yu, Bum‐Joon Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF
  Hyuk Kim, Jae-Young Kim, Yoon E. Shin, Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
  Hae Lim Lee, Soon Kyu Lee, Ji Won Han, Hyun Yang, Heechul Nam, Pil Soo Sung, Hee Yeon Kim, Sung Won Lee, Do Seon Song, Jung Hyun Kwon, Chang Wook Kim, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  JHEP Reports.2025; 7(7): 101391.     CrossRef
• Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
  Tyng‐Yuan Jang, Chia‐Yen Dai
  Advances in Digestive Medicine.2025;[Epub]     CrossRef
• Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
  Soon Kyu Lee, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(2): e161.     CrossRef
• Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
  Chih-Wen Wang, Ming-Lung Yu
  Clinical and Molecular Hepatology.2025; 31(2): 606.     CrossRef
• Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
  Soon Kyu Lee, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(2): e212.     CrossRef
• Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
  Jihye Lim, Hyundam Gu, Hyunji Sang, Su Jin Jeong, Ha Il Kim
  Alzheimer's Research & Therapy.2025;[Epub]     CrossRef
• Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study
  Napoleon Bellua Sam, Saeed Folorunsho Majeed, Adams Dramani
  Health Science Reports.2025;[Epub]     CrossRef
• A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B
  Jiwon Yang, Mark D. Muthiah, Won-Mook Choi
  Current Hepatology Reports.2025;[Epub]     CrossRef
• A greater frequency of circulating CCR7loPD-1hi follicular helper T cells indicates a durable clinical cure after Peg IFN-α therapy in chronic hepatitis B patients
  Shan Ren, Xiao Lin, Wenjing Wang, Wang Xiaoxiao, Lina Ma, Yanhong Zheng, Sujun Zheng, Xinyue Chen
  Hepatology Communications.2025;[Epub]     CrossRef
• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  Han Ah. Lee, Hyun Woong Lee, Yeon Seok Seo, Dong Hyun Sinn, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2025; 40(7): 1675.     CrossRef
• Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis
  Nobuharu Tamaki, Daniel Q. Huang, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Dong Hyun Sinn, Tae Seop Lim, Hiroyuki Marusawa, Seng Gee Lim, Hironori Ochi, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Masayuki Kurosaki, Beom Kyung K
  Journal of Gastroenterology and Hepatology.2025; 40(6): 1595.     CrossRef
• Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients
  Jihye Lim, Hyo Young Lee, Hyunji Sang, Su Jin Jeong, Ha Il Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis B
  Tyng-Yuan Jang, Yu-ting Zeng, Po-Cheng Liang, Chih-Da Wu, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Yi-Shan Tsai, Ming-Yen Hsieh, Yi-Hung Lin, Meng-Hsuan Hsieh, Chih-Wen Wang, Jeng-Fu Yang, Ming-Lun Yeh, Chung-Feng Huang, Wan-Long Chuang, Jee-Fu Huang, Batbo
  Journal of the Chinese Medical Association.2025; 88(5): 361.     CrossRef
• Concise Commentary: Gray Area—Underappreciated HCC Risk in Untreated “Gray Zone” and Immune-Tolerant CHB Patients
  Won-Mook Choi
  Digestive Diseases and Sciences.2025; 70(9): 2910.     CrossRef
• Immunizations in adult liver transplant candidates and recipients
  Dongwook Kim, Pyoeng Gyun Choe
  Annals of Liver Transplantation.2025; 5(1): 19.     CrossRef
• Emergency living donor liver transplantation
  Jongman Kim
  Annals of Liver Transplantation.2025; 5(1): 27.     CrossRef
• Association between maternal chronic hepatitis B virus infection and the neurodevelopment of children: A comprehensive Korean cohort study
  Yewan Park, Jihye Heo, Danbee Kang, Geum-Youn Gwak
  Preventive Medicine Reports.2025; 55: 103116.     CrossRef
• Letter on ‘Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma’. Authors' Reply
  Jiwon Yang, Won‐Mook Choi
  Alimentary Pharmacology & Therapeutics.2025; 62(2): 238.     CrossRef
• Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study
  Young Joo Park, Ki Youn Yi, Hyun Young Woo, Jeong Heo, Geun Am Song, Riccardo Nevola
  PLOS One.2025; 20(5): e0324019.     CrossRef
• Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
  Liang Wang, Shipeng Ma, Lajpat Rai Malhi, Xiaoping Wu, Liping Liu, Xin Wan, Yuliang Zhang, Xiaopeng Li, Shanfei Ge
  Annals of Hepatology.2025; 30(2): 101925.     CrossRef
• Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study
  Young Eun Chon, Jonghyun Lee, Eileen L. Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
  European Journal of Gastroenterology & Hepatology.2025;[Epub]     CrossRef
• Metabolic effects and cardiovascular disease risks of TDF or TAF in patients with chronic hepatitis B: a systematic review and meta-analysis
  Yuan-Hai Zhou, Nan Cai, Yu-Xin Chen, Yong-Lu Su, Peng Hu
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• A Case of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B Who was Not Under Surveillance Following the Loss of HBsAg
  Myeong Jun Song
  The Korean Journal of Gastroenterology.2025; 85(3): 425.     CrossRef
• Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
  Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
  Osteoporosis International.2025; 36(8): 1391.     CrossRef
• Longitudinal changes in estimated glomerular filtration rates in chronic hepatitis B patients treated with Tenofovir Alafenamide vs Entecavir
  Xuan Li, Qiang Wu, Fang Huang, Changxiang Lai, Fengjuan Chen, Juan Meng, Fang Wang, Hui Zeng, Lina Zhang
  PeerJ.2025; 13: e19901.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Annals of Surgical Treatment and Research.2025; 109(3): 123.     CrossRef
• Chronic hepatitis B: Is it time for expanded antiviral treatment?
  Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra
  World Journal of Virology.2025;[Epub]     CrossRef
• Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate
  Jiwon Yang, Jihye Lim, Ye‐Jee Kim, Hwa Jung Kim, Jonggi Choi
  Liver International.2025;[Epub]     CrossRef
• Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis
  Mi Na Kim, Geun U. Park, Seng Chan You, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn
  Journal of Gastroenterology and Hepatology.2025; 40(11): 2750.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Journal of Liver Cancer.2025; 25(2): 140.     CrossRef
• Comparative Renal Safety of Besifovir Dipivoxil Maleate and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients: Insights From a Nationwide Cohort Study
  Hyun Bin Choi, Jae Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Journal of Korean Medical Science.2025;[Epub]     CrossRef
• Distinguishing True Immune Tolerant Hepatitis B Patients: Insights From Long‐Term Clinical Outcomes
  Jung Hyun Kwon, Sung Won Lee, Hee‐Yeon Kim, Do Seon Song, Soon Kyu Lee, Heechul Nam, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  Journal of Viral Hepatitis.2025;[Epub]     CrossRef
• Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
  Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• Disease burden of chronic hepatitis B and C patients in South Korea: a population-based 16-year cohort study
  Oeuk Jeong, Changhee Chu, Jungyeon Kim, Jae Seung Lee, Jun Yong Park, Kyung Eun Lee, Jaehyun Seong, Min Jin Go
  BMC Infectious Diseases.2025;[Epub]     CrossRef
• Factors associated with TDF-to-TAF switching in chronic hepatitis B: A nationwide cohort study in South Korea
  Hyemin Ha, Kwang Il Seo, Nam Kyung Je
  Journal of Infection and Chemotherapy.2025; 31(12): 102860.     CrossRef
• Predicting risk factors for waiting mortality in adult emergent living donor liver transplantation based on Korean national data
  Sang Jin Kim, Jongman Kim, Kyunga Kim, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung
  Annals of Liver Transplantation.2025; 5(2): 107.     CrossRef
• Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
  Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Gwang Hyeon Choi, Yun Bin Lee, Dong Hyun Sinn, Young-Suk Lim
  Gut.2024; 73(4): 649.     CrossRef
• Gray zone of hepatitis B virus infection
  Young-Suk Lim
  Saudi Journal of Gastroenterology.2024; 30(2): 76.     CrossRef
• PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
  Ho Soo Chun, George V. Papatheodoridis, Minjong Lee, Hye Ah Lee, Yeong Hwa Kim, Seo Hyun Kim, Yun-Seo Oh, Su Jin Park, Jihye Kim, Han Ah Lee, Hwi Young Kim, Tae Hun Kim, Eileen L. Yoon, Dae Won Jun, Sang Hoon Ahn, Vana Sypsa, Cihan Yurdaydin, Pietro Lampe
  Journal of Hepatology.2024; 80(1): 20.     CrossRef
• Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment
  Hyeyeon Hong, Minjoo Cho, Chaeyeon Lim, Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Jonggi Choi
  Alimentary Pharmacology & Therapeutics.2024; 59(4): 515.     CrossRef
• Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy
  Liandong Wu, Zhenggang Yang, Min Zheng
  Journal of Viral Hepatitis.2024; 31(5): 255.     CrossRef
• Jaundice That Has Persisted for 5 Days
  Young Chang
  The Korean Journal of Medicine.2024; 99(3): 140.     CrossRef
• Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
  Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
  Diagnostics.2024; 14(5): 495.     CrossRef
• Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
  Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
  OncoTargets and Therapy.2024; Volume 17: 215.     CrossRef
• Linvencovir: Paving the way for functional cure in hepatitis B
  Jiwon Yang, Jonggi Choi
  Clinical and Molecular Hepatology.2024; 30(2): 164.     CrossRef
• Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
  Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
  JHEP Reports.2024; 6(7): 101089.     CrossRef
• Clinical profile and parameters of patients monoinfected with HBV and infected with HDV in Western Amazon
  Eugênia de Castro e Silva, Tárcio Peixoto Roca, Ana Maísa Passos-Silva, Lourdes Maria Pinheiro Borzacov, Adrhyan Araújo da Silva Oliveira, Jackson Alves da Silva Queiroz, Juan Miguel Villalobos Salcedo, Deusilene Vieira
  Heliyon.2024; 10(10): e31065.     CrossRef
• Macrophage-2-Binding Protein Glycosylation Isomer (M2BPGi) and AGAP Score as Markers of Noninvasive Test for Liver Fibrosis versus FibroScan in Chronic Hepatitis B Patients: A Retrospective Observational Study
  Laila Kurnia Pramono, Anna Tjandrawati, Dewi Kartika Turbawaty, Tiene Rostini, Muhammad Begawan Bestari, Haryono, Deny Budiman, Prapanca Nugraha, Dirk Uhlmann
  International Journal of Hepatology.2024; 2024: 1.     CrossRef
• Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis
  Jaejun Lee, Ahlim Lee, Pil Soo Sung, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hyun Yang
  The Korean Journal of Internal Medicine.2024; 39(4): 577.     CrossRef
• Treatment decisions based on HBV DNA
  Young‐Suk Lim
  Journal of Viral Hepatitis.2024; 31(S2): 36.     CrossRef
• Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
  Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, Chia‐Yen Dai
  Journal of Gastroenterology and Hepatology.2024; 39(11): 2327.     CrossRef
• Differential HBV replicative markers and covalently closed circular DNA transcription in immune‐active chronic hepatitis B with and without HBeAg
  Hye Seon Kim, Jin Seoub Kim, Ji Min Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam, Pil Soo Sung, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  Liver International.2024; 44(10): 2753.     CrossRef
• Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
  Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
  Clinical and Molecular Hepatology.2024; 30(3): 500.     CrossRef
• Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review
  Anadi Mahajan, Saifuddin Kharawala, Supriya Desai, Stuart Kendrick, Joyeta Das, Vera Gielen
  Journal of Viral Hepatitis.2024; 31(11): 746.     CrossRef
• Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
  Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Gwang Hyeon Choi, Won-Mook Choi, Jonggi Choi, Dong Hyun Sinn, Yong-Han Paik, Jeong-Hoon Lee, Yun Bin Lee, Ju-Yeon Cho, Nae-Yun Heo, Man-Fung Yuen, Vincent Wai-Sun Wong, Stephen L. Chan, Hwai-I Yang, Chien-Jen Chen
  Annals of Internal Medicine.2024; 177(10): 1308.     CrossRef
• Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis
  Jeong‐Ju Yoo, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Min Jae Kim
  Journal of the International AIDS Society.2024;[Epub]     CrossRef
• KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
  Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, D
  Clinical and Molecular Hepatology.2024; 30(Suppl): S5.     CrossRef
• Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis
  Young-Joo Jin, Hee Yeon Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun, Miyoung Choi, Seung Up Kim
  Clinical and Molecular Hepatology.2024; 30(Suppl): S159.     CrossRef
• Recent Trends in Noninvasive Tests for Assessing Hepatic Fibrosis in Patients with Chronic Liver Disease
  Jung Hwan Yu
  The Korean Journal of Medicine.2024; 99(5): 232.     CrossRef
• Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
  Yewan Park, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2024; 30(4): 718.     CrossRef
• Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography
  Han Ah Lee
  Clinical Ultrasound.2024; 9(2): 70.     CrossRef
• Effect of renin-angiotensin system inhibitor in incident cancer among chronic hepatitis B patients: An emulated target trial using a nationwide cohort
  Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  Journal of the Renin-Angiotensin-Aldosterone System.2024;[Epub]     CrossRef
• Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
  Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
  Infectious Agents and Cancer.2023;[Epub]     CrossRef
• Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
  Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee
  European Journal of Gastroenterology & Hepatology.2023; 35(4): 431.     CrossRef
• Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues
  Tyng‐Yuan Jang
  Alimentary Pharmacology & Therapeutics.2023; 57(5): 587.     CrossRef
• The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
  Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2023; 38(5): 716.     CrossRef
• Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
  Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Frontiers in Oncology.2023;[Epub]     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Journal of Liver Cancer.2023; 23(1): 1.     CrossRef
• Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study
  Moon Haeng Hur, Min Kyung Park, Terry Cheuk-Fung Yip, Chien-Hung Chen, Hyung-Chul Lee, Won-Mook Choi, Seung Up Kim, Young-Suk Lim, Soo Young Park, Grace Lai-Hung Wong, Dong Hyun Sinn, Young-Joo Jin, Sung Eun Kim, Cheng-Yuan Peng, Hyun Phil Shin, Chi-Yi Ch
  American Journal of Gastroenterology.2023; 118(11): 1963.     CrossRef
• Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
  Jeong-Ju Yoo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 513.     CrossRef
• The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
  Moon Haeng Hur, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(2): 363.     CrossRef
• Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
  Joo Hyun Oh, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2023; 29(2): 367.     CrossRef
• Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
  Eui Gwon Hwang, Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Hepatology International.2023; 17(4): 860.     CrossRef
• Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
  Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
  Alimentary Pharmacology & Therapeutics.2023; 58(1): 99.     CrossRef
• Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
  Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
  Diagnostics.2023; 13(9): 1537.     CrossRef
• CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B
  Hye Yeon Chon, Han Ah Lee, Soo Young Park, Yeon Seok Seo, Sang Gyune Kim, Chang Hun Lee, Tae Hee Lee, Sang Hoon Ahn, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Lilian Yan Liang, In Hee Kim, Grace Lai‐Hung Wong, Seung Up Kim
  Journal of Digestive Diseases.2023; 24(2): 113.     CrossRef
• Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study
  Jihye Kim, Moon Haeng Hur, Seung Up Kim, Jin-Wook Kim, Dong Hyun Sinn, Hyun Woong Lee, Moon Young Kim, Jae Youn Cheong, Yong Jin Jung, Han Ah Lee, Young-Joo Jin, Jun Sik Yoon, Sung-Jae Park, Chang Hun Lee, In Hee Kim, June Sung Lee, Young Youn Cho, Hyung
  Cancers.2023; 15(11): 2936.     CrossRef
• Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALT
  宇行 刘
  Advances in Clinical Medicine.2023; 13(05): 8702.     CrossRef
• Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
  Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang
  BMC Cancer.2023;[Epub]     CrossRef
• Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
  Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
  BMC Gastroenterology.2023;[Epub]     CrossRef
• A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Liver International.2023; 43(8): 1813.     CrossRef
• Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non‐cirrhotic patients with chronic hepatitis B
  Cheol‐Hyung Lee, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
  Alimentary Pharmacology & Therapeutics.2023; 58(7): 704.     CrossRef
• The efficacy of treatment for hepatocellular carcinoma in elderly patients
  Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
  Journal of Liver Cancer.2023; 23(2): 362.     CrossRef
• Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia
  Grace Chung‐Yan Lui, Grace Lai‐Hung Wong, Hung‐Chih Yang, Wang‐Huei Sheng, Sun Hee Lee
  HIV Medicine.2023; 24(10): 1035.     CrossRef
• Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
  Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Adult-onset hypophosphatemic osteomalacia as a cause of widespread musculoskeletal pain: A retrospective case series of single center experience
  Sungwon Kim, Sun Woong Kim, Byung Chan Lee, Du Hwan Kim, Duk Hyun Sung
  World Journal of Clinical Cases.2023; 11(32): 7785.     CrossRef
• Hepatocellular carcinoma presenting as organized liver abscess: A case report
  Sung Hyeok Ryou, Hyun Deok Shin, Suk Bae Kim
  World Journal of Clinical Cases.2023; 11(33): 8078.     CrossRef
• The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
  Jung Kim, Sung-Eun Kim, Do Song, Hee Kim, Eileen Yoon, Seong Kang, Young-Kul Jung, Jung Kwon, Sung Lee, Seul Han, Young Chang, Soung Jeong, Jeong Yoo, Young-Joo Jin, Gab Cheon, Byung Kim, Yeon Seo, Hyoungsu Kim, Ji Park, Tae Kim, Dong Sinn, Woo Chung, Hwi
  Diagnostics.2023; 14(1): 14.     CrossRef
• Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
  Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
  Clinical and Molecular Hepatology.2023; 30(1): 49.     CrossRef
• Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
  Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
  Medicine.2023; 102(43): e34276.     CrossRef
• Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
  Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Scientific Reports.2022;[Epub]     CrossRef
• Reply to: “A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations”
  Hyun Yang, Si Hyun Bae, Jeong Won Jang
  Journal of Hepatology.2022; 77(6): 1724.     CrossRef
• Viral Hepatitis in Patients with Inflammatory Bowel Disease
  Seung Hwan Shin, Sang Hyoung Park
  The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Clinical and Molecular Hepatology.2022; 28(4): 583.     CrossRef
• 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
  
  Korean Journal of Radiology.2022; 23(12): 1126.     CrossRef
• Updated Treatment Guidelines for Chronic Hepatitis B
  Jihyun An
  The Korean Journal of Medicine.2022; 97(6): 353.     CrossRef

Citations

Citations to this article as recorded by  

• Association Between Sociodemographic Variables, Healthy Habits, and Stress with Risk Scales for Liver Disease Associated with Metabolic Dysfunction
  Ángel Arturo López-González, Emilio Martínez-Almoyna Rifá, Hernán Paublini Oliveira, Cristina Martorell Sánchez, Pedro Juan Tárraga López, José Ignacio Ramírez-Manent
  Life.2025; 15(1): 116.     CrossRef
• Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
  Pojsakorn Danpanichkul, Kanokphong Suparan, Vitchapong Prasitsumrit, Aijaz Ahmed, Karn Wijarnpreecha, Donghee Kim
  Clinical and Molecular Hepatology.2025; 31(1): 74.     CrossRef
• Non alkolik yağlı karaciğer hastalığı ile kafein alımı arasındaki ilişki
  İzel Akkaya, İlknur Gökçe Yıldırım
  Sağlık Profesyonelleri Araştırma Dergisi.2025; 7(1): 47.     CrossRef
• Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases
  Baoqiang Ni, Lingqun Ye, Yan Zhang, Shijun Hu, Wei Lei
  Journal of Translational Medicine.2025;[Epub]     CrossRef
• Association of High‐Sensitivity Troponins in Metabolic Dysfunction‐Associated Steatotic Liver Disease With All‐Cause and Cause‐Specific Mortality
  Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
  Alimentary Pharmacology & Therapeutics.2025; 61(11): 1785.     CrossRef
• Investigating the Mechanisms of Lycii fructus in Treating Nonalcoholic Fatty Liver Disease and Diabetes Comorbidity Through Network Pharmacology and Molecular Dynamics
  Peng Sun, Jiahui Song, Yang Liu, Xiujing Li, Yiming Zhang, Yuxing Zhou, Wei Gong
  Food Science & Nutrition.2025;[Epub]     CrossRef
• Increased BMD in SLD Patients Without Advanced Hepatic Fibrosis: Evidence From the NHANES 2017–2020 Database
  Tianhao Wu, Lu Li, Yayuan Mei, Peizhen Lv, Jiawei Cui, Lin Liu, Yuemin Nan, Ang Li, Yu-Chen Fan
  Canadian Journal of Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence
  Wenqi Dong, Haiming Zhang, Shaowei Mu, Shuyi Shi, Junli Zhang, Keshu Xu
  Clinical Pharmacology & Therapeutics.2025;[Epub]     CrossRef
• Extrahepatic Comorbidities Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease; A Tertiary Hospital Experience
  Masoudreza Sohrabi, Mozhdeh Mosalli, Parvin Hassanzadeh, Somayeh Bahrami, Mahmoodreza Khoonsari, Hossein Ajdarkosh, Farhad Zamani
  Middle East Journal of Digestive Diseases.2025; 17(2): 96.     CrossRef
• Causal Relationship between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Bidirectional Two-Sample Mendelian Randomization Study
  恒 杨
  Advances in Clinical Medicine.2024; 14(04): 101.     CrossRef
• Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research
  E. V. Biryukova
  Meditsinskiy sovet = Medical Council.2024; (6): 72.     CrossRef
• Association between obesity phenotypes and non-alcoholic fatty liver: a large population- based study
  Farid Najafi, Yahya Pasdar, Mehdi Moradi Nazar, Mitra Darbandi
  BMC Endocrine Disorders.2024;[Epub]     CrossRef
• Masquerading Spleen: A Perplexing Case of Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma
  Noriko Ikeda, Yujo Kawashita, Masaki Tateishi, Takashi Ueda, Junzo Yamaguchi, Yasuo Washida, Yoichi Hachitanda
  Cureus.2024;[Epub]     CrossRef
• Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification
  Min Kyu Kang, Jeong Eun Song, Rohit Loomba, Soo Young Park, Won Young Tak, Young Oh Kweon, Yu Rim Lee, Jung Gil Park
  Scientific Reports.2024;[Epub]     CrossRef
• Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease
  Ho Soo Chun, Minjong Lee, Hye Ah Lee, Seo Yeong Oh, Hyo Jeong Baek, Jae Won Moon, Yeon Jeong Kim, Jinha Lee, Hyoeun Kim, Hwi Young Kim, Kwon Yoo, Tae Hun Kim, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2023; 21(2): 358.     CrossRef
• Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
  Yoon-a Hwang, Hye Won Lee, Sang Hoon Ahn, Eun Jig Lee, Cheol Ryong Ku, Seung Up Kim
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
  Ho Soo Chun, Minjong Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Ji‐Hye Kim, Seung Up Kim
  Liver International.2023; 43(3): 608.     CrossRef
• Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
  Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
  Clinical and Molecular Hepatology.2023; 29(Suppl): S286.     CrossRef
• Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease
  Maryam K. Ibrahim, Tracey G. Simon, Mary E. Rinella
  Clinics in Liver Disease.2023; 27(2): 251.     CrossRef
• Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
  Jung Hwan Yu, Han Ah Lee, Seung Up Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S136.     CrossRef
• Screening strategy for non-alcoholic fatty liver disease
  Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
  Clinical and Molecular Hepatology.2023; 29(Suppl): S103.     CrossRef
• Diabetes and cirrhosis: Current concepts on diagnosis and management
  Laurent Castera, Kenneth Cusi
  Hepatology.2023; 77(6): 2128.     CrossRef
• Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI‐PDFF in NAFLD
  Beom K. Kim, Nicole Bernstein, Daniel Q. Huang, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajim
  Alimentary Pharmacology & Therapeutics.2023; 58(2): 229.     CrossRef
• MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
  Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2023; 38(9): 1598.     CrossRef
• Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study
  Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Sung Chul Choi, Yun Soo Hong, Yewan Park, Juhee Cho, Geum-Youn Gwak, Ahmed Mustafa Rashid
  PLOS ONE.2023; 18(7): e0288820.     CrossRef
• Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
  Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim, Jae Youn Cheong
  Gut and Liver.2023; 17(4): 610.     CrossRef
• Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study
  Beom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem K. Oz, Ayse Erden, Emily Truong, Ju Dong Yang, Mazen Noureddin, Alina M. Allen, Rohit Loomba, Veeral Ajmera
  Hepatology.2023; 78(6): 1858.     CrossRef
• Polycystic ovary syndrome in pediatric obesity and diabetes
  Elena DONDI, Maria TUFANO, Maria C. VIGONE, Laura LUCACCIONI, Gabriella POZZOBON, Graziamaria UBERTINI, Enza MOZZILLO, Maurizio DELVECCHIO
  Minerva Pediatrics.2022;[Epub]     CrossRef
• Mouse liver injury induces hepatic macrophage FGF23 production
  Pradeep Kumar, Yunshan Liu, Yang Shen, Jacquelyn J. Maher, Francesca Cingolani, Mark J. Czaja, Matias A Avila
  PLOS ONE.2022; 17(3): e0264743.     CrossRef
• New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
  Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Bogdan-Mircea Mihai
  Life.2022; 12(8): 1189.     CrossRef
• Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
  Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
  Clinical and Molecular Hepatology.2022; 28(4): 725.     CrossRef
• Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes
  Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Bogdan-Mircea Mihai
  Biomedicines.2022; 10(10): 2375.     CrossRef
• Intestinal microbiota in the treatment of metabolically associated fatty liver disease
  Ji-Shuai Wang, Jin-Chun Liu
  World Journal of Clinical Cases.2022; 10(31): 11240.     CrossRef
• A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review
  Chowdhury F Zaman, Jakia Sultana, Proma Dey, Jui Dutta, Sadia Mustarin, Nuzhat Tamanna, Aditi Roy, Nisha Bhowmick, Mousumi Khanam, Sadia Sultana, Selia Chowdhury, Farjana Khanam, Md Sakibuzzaman, Priyata Dutta
  Cureus.2022;[Epub]     CrossRef
• The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials
  Carmine Izzo, Monica Annunziata, Giuseppe Melara, Roberta Sciorio, Marcello Dallio, Mario Masarone, Alessandro Federico, Marcello Persico
  Nutrients.2021; 13(3): 933.     CrossRef
• Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
  Ho Soo Chun, Mi Na Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Journal of Cachexia, Sarcopenia and Muscle.2021; 12(5): 1168.     CrossRef
• The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation‐wide Cohort Study
  Yewan Park, Dong Hyun Sinn, Joo Hyun Oh, Myung Ji Goh, Kyunga Kim, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Geum‐Youn Gwak
  Hepatology.2021; 74(6): 2988.     CrossRef
• Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus
  Kiyoung Lim, Minkyu Kang, Junggil Park
  Nutrients.2021; 13(10): 3400.     CrossRef
• Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
  Eun-Ju Cho, Gu-Cheol Jung, Min-Sun Kwak, Jong-In Yang, Jeong-Yoon Yim, Su-Jong Yu, Goh-Eun Chung
  Diagnostics.2021; 11(12): 2233.     CrossRef
• Non‑alcoholic fatty liver disease and hematologic manifestations (Review)
  Vlad Pădureanu, Dalia Dop, Alice Drăgoescu, Rodica Pădureanu, Anca Mușetescu, Laurențiu Nedelcu
  Experimental and Therapeutic Medicine.2021;[Epub]     CrossRef
• Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
  Marcello Dallio, Moris Sangineto, Mario Romeo, Rosanna Villani, Antonino Davide Romano, Carmelina Loguercio, Gaetano Serviddio, Alessandro Federico
  International Journal of Molecular Sciences.2021; 22(1): 436.     CrossRef
• Nutraceutical correction in the complex non-drug treatment of metabolic syndrome
  L.G. Agasarov, T.V. Apkhanova, V.N. Sergeev, A.D. Fesun, M.M. Krukova, V.A. Vasilyeva, D.B. Kulchitskaya, T.V. Konchugova, G.A. Puzyreva, M.Yu. Yakovlev
  Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury.2021; 98(4): 25.     CrossRef

Citations

Citations to this article as recorded by  

• Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis
  Bryony Simmons, Jawaad Saleem, Andrew Hill, Richard D. Riley, Graham S. Cooke
  Clinical Infectious Diseases.2016; 62(6): 683.     CrossRef
• Efficacy of Peginterferon and Ribavirin Combination Therapy of Chronic Hepatitis C: A Pooled Analysis
  Soo Yong Park, Min Young Rim, In Ku Yo, Min Su Ha, Ju Seung Kim, Ji Won Lee, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
  The Korean Journal of Gastroenterology.2012; 60(5): 306.     CrossRef
• Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long‐term follow‐up
  D. Maruoka, F. Imazeki, M. Arai, T. Kanda, K. Fujiwara, O. Yokosuka
  Journal of Viral Hepatitis.2012;[Epub]     CrossRef
• Chronic Hepatitis C
  Jae Young Jang, Raymond T. Chung
  Gut and Liver.2011; 5(2): 117.     CrossRef
• Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin
  Kyung-Ah Kim
  The Korean Journal of Hepatology.2011; 17(1): 84.     CrossRef
• Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response
  Jeong Heo
  The Korean Journal of Hepatology.2011; 17(3): 180.     CrossRef
• Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
  Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol
  The Korean Journal of Hepatology.2011; 17(3): 183.     CrossRef
• Durability of Sustained Virologic Response in Chronic Hepatitis C: Analysis of Factors Related to Relapse after Sustained Virologic Response with Peginterferon Plus Ribavirin Combination Therapy
  Jang Eun Lee, Na Ri Yoon, Jin Dong Kim, Myeong Jun Song, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Sung Won Jeong, Seung Kew Yoon
  The Korean Journal of Gastroenterology.2011; 57(3): 173.     CrossRef
• Long-Term Effects of Antiviral Therapy in Patients with Chronic Hepatitis C
  Tatehiro Kagawa, Emmet B. Keeffe
  Hepatitis Research and Treatment.2010; 2010: 1.     CrossRef